COVID-19
WELCOME TO THE EJSU COVID-19 INFORMATION PAGE
The COVID-19 Information Page was set up to assist in communication and information distribution during the COVID-19/Coronavirus pandemic. Some of the content due to its classification is stored on the Defence Gateway. Please ensure you have a Defence gateway username and password before proceeding. For assistance on getting a Defence Gateway account please follow this link
Vaccine Development Information
Title | Type of Vaccine | Current Phase | Location of Research |
---|---|---|---|
Ad5-nCoV | Recombinant vaccine (adenovirus type 5 vector) | Phase 3 | Tongji Hospital; Wuhan, China |
AZD1222 | Replication-deficient viral vector vaccine (adenovirus from chimpanzees) | Phase 3 | The University of Oxford, the Jenner Institute |
CoronaVac | Inactivated vaccine (formalin with alum adjuvant) | Phase 3 | Sinovac Research and Development Co., Ltd. |
mRNA-1273 | mRNA-based vaccine | Phase 3 | Kaiser Permanente Washington Health Research Institute |
No name announced | Inactivated vaccine | Phase 3 | Henan Provincial Centre for Disease Control and Prevention |